Effectiveness and cost-effectiveness of combination therapy versus monotherapy in malignant melanoma
ConclusionCombination therapy is more effective compared to monotherapy. While combined ICIs are cost-effective compared to monotherapy, this is not the case for the combination of BRAF and MEK inhibitors.
Source: Journal of Pharmaceutical Policy and Practice - Category: Pharmaceuticals Source Type: research
More News: Cancer & Oncology | Clinical Trials | Databases & Libraries | Fibrosarcoma | Melanoma | Pharmaceuticals | Science | Skin Cancer